SS Innovations International (SSII) EBITDA (2016 - 2026)
SS Innovations International recorded quarterly EBITDA of -$5.1 million in Q1 2026, down 60.95% quarter-over-quarter from -$3.2 million in Q4 2025, and up 9.29% year-over-year from -$4.7 million in Q1 2025.
SS Innovations International's EBITDA history runs 11 years deep, the most recent figure standing at -$5.1 million for Q1 2026.
- In Q1 2026, EBITDA rose 9.29% year-over-year to -$5.1 million; the TTM figure through Mar 2026 stood at -$12.9 million (up 16.68% YoY), while the FY2025 annual figure was -$13.4 million, up 32.0% from the prior year.
- EBITDA came in at -$5.1 million for Q1 2026 at SS Innovations International, down from -$3.2 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$80421.0 in Q1 2022 to a low of -$12.2 million in Q4 2023.
- A 5-year average of -$3.6 million and a median of -$3.2 million in 2025 frame the typical range for EBITDA.
- Across the five-year window, EBITDA plunged 1587.79% in 2023 and jumped 91.51% in 2025, its largest moves.
- SS Innovations International's EBITDA stood at -$856480.0 in 2022, then slumped by 1323.74% to -$12.2 million in 2023, then jumped by 80.87% to -$2.3 million in 2024, then slumped by 36.71% to -$3.2 million in 2025, then slumped by 60.95% to -$5.1 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$5.1 million, -$3.2 million, and -$4.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | -5.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.13 Mn |
| Dec 31, 2025 | -3.19 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Jun 30, 2025 | -352,593.00 |
| Mar 31, 2025 | -5.66 Mn |
| Dec 31, 2024 | -2.33 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | -4.15 Mn |
| Mar 31, 2024 | -9.91 Mn |
| Dec 31, 2023 | -12.19 Mn |
| Sep 30, 2023 | -2.03 Mn |
| Jun 30, 2023 | -5.54 Mn |
| Mar 31, 2023 | -1.36 Mn |
| Dec 31, 2022 | -856,480.00 |
| Sep 30, 2022 | -400,691.00 |
| Jun 30, 2022 | -701,752.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -353,735.00 |
| Sep 30, 2021 | -418,209.00 |
| Jun 30, 2021 | -412,314.00 |
| Mar 31, 2021 | -300,056.00 |
| Dec 31, 2020 | -221,750.00 |
| Sep 30, 2020 | -375,213.00 |
| Jun 30, 2020 | -219,988.00 |
| Mar 31, 2020 | -306,671.00 |
| Dec 31, 2019 | -1.05 Mn |
| Sep 30, 2019 | -1.39 Mn |
| Jun 30, 2019 | -532,507.00 |
| Mar 31, 2019 | -394,326.00 |
| Dec 31, 2018 | -219,137.00 |
| Sep 30, 2018 | -297,272.00 |
| Jun 30, 2018 | -205,509.00 |
| Mar 31, 2018 | -238,404.00 |
| Dec 31, 2017 | -473,964.00 |
| Sep 30, 2017 | -171,067.00 |
| Jun 30, 2017 | -178,376.00 |
| Mar 31, 2017 | -187,315.00 |
| Dec 31, 2016 | -185,840.00 |
| Sep 30, 2016 | -236,888.00 |
| Jun 30, 2016 | -39,701.00 |